Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Results of a New Virtual Program for Patients Overdue for Diabetic Retinopathy Evaluation.

Ophthalmology and therapy·2025
Same author

Guidelines for the Diagnosis, Management, and Study of Autoimmune Retinopathy from the American Academy of Ophthalmology's Task Force.

Ophthalmology. Retina·2025
Same author

Safety and Target Engagement of Complement C1q Inhibitor ANX007 in Neurodegenerative Eye Disease: Results from Phase I Studies in Glaucoma.

Ophthalmology science·2023
Same author

C1q and the classical complement cascade in geographic atrophy secondary to age-related macular degeneration.

International journal of retina and vitreous·2022
Same author

Factors Affecting Compliance with Diabetic Retinopathy Screening: A Qualitative Study Comparing English and Spanish Speakers.

Clinical ophthalmology (Auckland, N.Z.)·2022
Same author

Topical Medication Adherence and Visual Field Progression in Open-angle Glaucoma: Analysis of a Large US Health Care System.

Journal of glaucoma·2021

Related Experiment Video

Updated: May 28, 2026

Modeling Cataract Surgery in Mice
05:19

Modeling Cataract Surgery in Mice

Published on: December 1, 2023

Recent statin use and cataract surgery.

Donald S Fong1, Kwun-Yee T Poon

  • 1Department of Ophthalmology, Southern California Permanente Medical Group, Baldwin Park, CA 91101, USA. Donald.s.fong@kp.org

American Journal of Ophthalmology
|October 11, 2011
PubMed
Summary

Longer-term statin use appears protective against cataract surgery in younger adults, while shorter-term use increases risk. Further research is needed to understand these differing effects of statins on cataract development.

Related Experiment Videos

Last Updated: May 28, 2026

Modeling Cataract Surgery in Mice
05:19

Modeling Cataract Surgery in Mice

Published on: December 1, 2023

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Epidemiology

Background:

  • Cataract extraction is a common surgical procedure.
  • Statins are widely prescribed medications for cardiovascular health.

Purpose of the Study:

  • To investigate the association between statin use and the risk of cataract extraction.
  • To determine if the duration of statin use influences this risk.

Main Methods:

  • A case-control study was conducted using electronic health records from Kaiser Permanente Southern California.
  • 13,982 patients who underwent cataract surgery (cases) and 34,049 controls were analyzed.
  • Statin use, duration, and other risk factors were assessed via electronic databases.

Main Results:

  • Longer-term statin use (≥5 years) was associated with a reduced risk of cataract extraction (OR: 0.93, P = .02).
  • Shorter-term statin use (<5 years) was associated with an increased risk of cataract surgery (OR: 1.11, P < .0001).
  • This protective effect of longer-term statin use was primarily observed in younger patients (50-64 years).

Conclusions:

  • Recent, longer-term statin use may be protective against cataract surgery, particularly in younger individuals.
  • Shorter-term statin use appears to be associated with an increased risk of cataract surgery.
  • Additional research is required to elucidate the differential effects of statin duration on cataract development.